Molluscum contagiosum is a benign poxvirus skin infection causing small dome-shaped bumps with a central dimple. The Skin Doctor confirms the diagnosis and tailors management, with particular focus on eczema control (a major driver of widespread molluscum) and in-clinic options including cantharidin — often painless at application and well-suited to multiple lesions.
- Molluscum is harmless but can take months to resolve on its own.
- It spreads by skin contact, shared items and self-spread from scratching.
- Poorly controlled eczema is the most common reason molluscum becomes widespread.
- Cantharidin is often a strong option for multiple lesions — painless at application, with controlled blistering afterwards.
- Young children using cantharidin must be supervised — keeping medication away from eyes is critical.
- Adults can also get molluscum, including in genital areas, which warrants doctor-led management.
Molluscum Contagiosum
Molluscum contagiosum is a benign viral skin infection caused by a poxvirus. It produces small, smooth bumps that often have a central dimple (umbilication). Molluscum is common in children but adults get it too, and lesions can appear almost anywhere on the body. It is harmless and often resolves naturally, but it can take months — and it can spread on the skin and to other people. One of the most common reasons molluscum becomes widespread is poorly controlled eczema.

By Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA
Last reviewed 2026-06-06 · Editorial policy
Molluscum contagiosum is a benign viral skin infection (a poxvirus) that causes small, smooth bumps that often have a central dimple. (1–3) It’s common in children, but adults get it too, and lesions can appear anywhere on the body. (1–4)
What is molluscum contagiosum?
Molluscum contagiosum is a viral infection limited to the upper layers of skin. It causes clusters of small bumps that can appear on the trunk, limbs, skin folds, and sometimes the face. In adults, it can also occur in the genital area (managed a little differently because of skin sensitivity and transmission context). (1–4) It is not dangerous and is not linked to skin cancer.
What does it look like?
Typical features:
- small (often 1–5 mm) smooth, dome-shaped bumps
- flesh-coloured, white-pearly, or pink
- a central dimple (“umbilication”) is common
- bumps may become red and inflamed when the immune system starts clearing them (1–3)
How it spreads
Molluscum spreads via: (1–4)
- direct skin-to-skin contact
- shared items (towels, razors, gym gear)
- autoinoculation (self-spread) from scratching, shaving, or friction
Practical steps that help:
- don’t pick or squeeze lesions
- avoid shaving over lesions
- keep nails short (reduces scratching damage)
- cover lesions for sport/swimming where practical
- don’t share towels or razors (1–4)
Molluscum and eczema: the most common reason it spreads widely
If you or your child has molluscum that seems to be “multiplying” quickly, a very common driver is poorly controlled eczema (atopic dermatitis). (1–3) Here’s why:
- eczema makes the skin itchy → scratching spreads virus
- eczema creates microscopic breaks in the skin barrier → the virus can seed into nearby skin far more easily
- inflamed, dry skin is simply a better “surface” for molluscum to propagate (1–3)
This is why treating the eczema is often the turning point. Learn more about effective treatment of Eczema here
Treatment options
Treatment is optional, but often worthwhile if lesions are:
- spreading quickly
- itchy/inflamed or causing eczema flares
- cosmetically bothersome
- in areas of friction (where they spread easily)
- persistent over many months (1–3)
Common options include:
- Watchful waiting (often reasonable, especially if mild) (1–3)
- Cantharidin (in-clinic) (excellent for multiple lesions) (2,3,5)
- Curettage (physical removal; quick but can be uncomfortable) (1–3)
- Cryotherapy (freezing; effective but can sting and may require repeats) (1–3)
- Topical prescriptions in selected cases (e.g., topical retinoids or clinician-directed options; evidence and tolerability vary) (1–3)
Cantharidin treatment: step-by-step (what to expect)
Cantharidin is a topical blistering agent used in-clinic to create a controlled separation of the lesion from the skin surface as it heals. It’s widely used because it can be efficient for multiple lesions, and there is usually no pain at the time it’s applied (discomfort, if it occurs, is typically later when blistering begins). (2,3,5)
In the clinic
We confirm the diagnosis and select lesions appropriate for cantharidin (site and skin sensitivity matters). Dr Chris applies a tiny drop of cantharidin solution directly onto each lesion. We then place a lightly-attached occlusive dressing over the treated area. This helps protect the area and encourages controlled contact with the lesion.
At home (the incubation phase)
You go home and keep the dressing on for about 4 hours, or until blistering begins (your exact timing will be explained on the day based on skin site and sensitivity). After the incubation time, you remove the dressing and wash the area thoroughly with soap and water to ensure all medication is removed.
What happens next
Over the next 12–48 hours, treated lesions may blister, become tender, then crust and heal. Lesions typically resolve as the blister roof sheds and healthy skin reforms. Some people need more than one treatment session depending on lesion number, size, and how reactive the skin is. (2,3,5)
Why we like cantharidin for multiple lesions
- Efficient when there are many bumps
- Often well tolerated in children because the application itself is usually painless
- Minimises the need for repeated freezing pain or curettage discomfort (2,3,5)
Safety warnings (especially for young children)
This section is important.
Eye risk during home incubation
While cantharidin is on the skin under a dressing, young children must be closely supervised. If a child removes the dressing, touches the medication, and then touches their eyes, it can cause serious irritation and injury. (5) What we advise:
- keep the treated area covered and supervised during incubation
- avoid naps unsupervised in very young children during the incubation window
- wash hands after any contact with the treated area
- remove the dressing and wash promptly at the instructed time
Where we avoid or use extra caution
Cantharidin is generally used cautiously on very sensitive areas and near mucous membranes (especially eyes). Your suitability depends on lesion location and skin sensitivity. (2,3,5)
Aftercare and prevention
- Don’t pick crusts (reduces scarring and pigment marks)
- Keep the area clean and follow dressing instructions
- Manage itch and eczema aggressively to prevent new lesions (see Eczema patient hub page)
- Avoid shaving over lesions and avoid sharing towels/razors (1–4)
Book
If you want confirmation of diagnosis, advice on spread prevention, and treatment options that fit your situation, book a review at our Ivanhoe or Diamond Creek clinic.
Symptoms
- Small smooth dome-shaped bumps
- A central dimple (umbilication)
- Flesh-coloured, white-pearly or pink
- Bumps may become red and inflamed when clearing
- Clusters on the trunk, limbs, skin folds and sometimes the face
- Can spread to nearby skin (autoinoculation)
Causes & contributors
- Molluscum contagiosum virus (a poxvirus) infecting the upper layers of skin
- Spread by direct skin-to-skin contact
- Spread by shared items (towels, razors, gym gear)
- Self-spread (autoinoculation) from scratching, shaving or friction
- Poorly controlled eczema is a major driver of widespread spread — the impaired barrier and itch-scratch cycle let the virus seed into nearby skin
Diagnosis
Molluscum contagiosum is usually diagnosed clinically — the smooth dome-shaped bumps with a central dimple are characteristic and dermoscopy supports the diagnosis. In adults, lesions in the genital area need careful counselling about transmission. In children with widespread molluscum, looking for and treating underlying eczema is often the turning point.
Treatment options
Watchful waiting
Often a reasonable approach, especially if mild — but resolution can take many months.
Cantharidin (in-clinic)
A topical blistering agent applied in clinic. Typically painless at application, then creates controlled blistering and separation of the lesion. Often an excellent option for multiple lesions, particularly in children, because there is no pain at the time of treatment.
Curettage
Physical removal in clinic. Quick but can be uncomfortable, especially for young children and on sensitive sites.
Cryotherapy
Effective for selected lesions but can sting and may need repeat sessions.
Eczema control
For patients with eczema, controlling the eczema is often the most important intervention to slow spread — see Eczema for routine and flare plans.
Topical prescriptions in selected cases
Topical retinoids or other clinician-directed options may be considered. Evidence and tolerability vary.
When to see a doctor
Book a review if you are unsure of the diagnosis, if lesions are spreading quickly, if they are itchy or inflamed and causing eczema flares, if they are cosmetically bothersome, if they are in areas of friction (where they spread easily), or if they have been persistent over many months. Adult genital-area lesions warrant doctor-led management.
Frequently asked questions
-
Is molluscum dangerous?
No. It’s benign. The main issues are spread, irritation, and eczema flares. -
Why are my lesions getting red?
That can be a sign your immune system is starting to clear them — but it can also happen if they’re irritated by friction or scratching. -
Do adults get molluscum?
Yes. Adults can get molluscum, and genital-area lesions can occur via skin contact. -
What’s the fastest way to stop it spreading?
Control eczema/itch, avoid scratching, cover lesions where practical, and consider in-clinic therapy (often cantharidin when there are multiple lesions).
References
- DermNet NZ. Molluscum contagiosum.
- van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit LWA, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017;5(5):CD004767.DOI: 10.1002/14651858.CD004767.pub4
- Meza-Romero R, Navarrete-Dechent C, Downey C. Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment. Clin Cosmet Investig Dermatol. 2019;12:373-381.DOI: 10.2147/CCID.S187224
- Centers for Disease Control and Prevention. Molluscum contagiosum.
- US Food and Drug Administration. YCANTH (cantharidin) topical solution, 0.7% — prescribing information. 2023.
- Australasian College of Dermatologists. Molluscum contagiosum.
- Badri T, Gandhi GR. Molluscum contagiosum. StatPearls (NCBI Bookshelf).
Related
Medically reviewed by Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA · Last reviewed 2026-06-06 · Editorial policy